scispace - formally typeset
F

Freddie Bray

Researcher at International Agency for Research on Cancer

Publications -  452
Citations -  345102

Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.

Papers
More filters
Journal ArticleDOI

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis

TL;DR: Among the different tumor sites, the highest expected relative increase by 2025 in treatment courses was prostate cancer while lymphoma, head and neck and breast cancer were below the average.
Journal ArticleDOI

The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies

TL;DR: The findings from the current meta-analysis suggest that DM may be both associated with elevated risks of both HCC incidence and mortality and HCC patients with pre-existing diabetes have a poorer prognosis relative to their non-diabetic counterparts.
Journal ArticleDOI

Interpreting the international trends in testicular seminoma and nonseminoma incidence.

TL;DR: Trends in the incidence of germ cell tumors are examined using high-quality cancer-registry data from 41 populations within 14 countries worldwide, lending support to the conclusion that the subtypes are epidemiologically and etiologically comparable.
Journal ArticleDOI

Age-Incidence Curves of Nasopharyngeal Carcinoma Worldwide: Bimodality in Low-Risk Populations and Aetiologic Implications

TL;DR: Using data from 23 high-quality population-based cancer registries for the period 1983-1997, a key finding was the consistent pattern of bimodality that emerged across low-risk populations, irrespective of geographic location.
Journal ArticleDOI

Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends.

TL;DR: The challenge for countries heavily affected by the disease in these regions is to ensure resource‐dependent programmes of screening and vaccination are implemented to transform the situation, so that accelerated declines in cervical cancer are not the preserve of high‐income countries, but become the norm in all populations worldwide.